Adamis Pharmaceuticals Corp (NASDAQ:ADMP)

Delayed Data
As of May 20
 -0.0346 / -7.73%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Adamis Pharmaceuticals Corp have a median target of 1.50, with a high estimate of 1.50 and a low estimate of 1.50. The median estimate represents a +259.02% increase from the last price of 0.42.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Hold stock in Adamis Pharmaceuticals Corp. This rating has held steady since December, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 15

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 50.00%
Growthannually 39.58%


Growthquarterly 58.94%
Growthannually 449.90%
Key to the earnings and sales forecast charts.